Peri-launch activity

Policies undertaken around the launch of a medicine on the market. Related to the entry of new medicines, this might be specific arrangements (e.g. managed-entry agreements, HTA) during the pricing and reimbursement decision process. Peri-launch activities address, among other things, issues of access and affordability.

Last update: 20 June 2023

Source: PPRI